J&J Consumer Products Business Steers Toward Acquisitions For Growth
This article was originally published in The Rose Sheet
Executive Summary
Firm continues to be outspoken about its M&A appetite, recently closing deals for Vogue International and NeoStrata, among others. Neutrogena and Aveeno were top performers for J&J’s Consumer business in the second quarter, the company says.
You may also be interested in...
J&J Consumer Health More Than A Revenue Stream: Driving Development Across Segments
CEO Alex Gorsky and medtech business leader Joaquin Duato say consumers’ growing interest in self-care is influencing the firm’s work across segments. Consumer health also is driver for Healthy Lives Mission to invest $800m through 2030 to improve the health of people and the world.
Balancing Beauty Lineup With International And Regional Brands Factors In J&J Consumer Growth
While J&J benefits from “underlying strength” of its large skin care brands, it targets “regular additions of local, smaller brands,’ says global consumer business head Thibaut Mongon. Portfolio balance of international and localized brands helps it weather economic uncertainty during the COVID-19 pandemic.
J&J Highlights Plans For Reinventing Johnson’s Baby, Globalizing Aveeno
A planned restage of Johnson’s Baby will “completely reinvent the brand,” says Jorge Mesquita, global chairman of the J&J’s consumer division. Meanwhile, the firm is working to unfetter “captive” regional brands, expanding OGX and Aveeno across the globe while bringing Le Petit Marseillais to North America, among other growth initiatives.